What is Lutetium Lu 177 Vipivotide Tetraxetan: Uses, Dosage, Side Effects and More

Lutetium Lu 177 vipivotide tetraxetan is a targeted radioactive cancer treatment designed specifically for men with advanced prostate cancer. This medication works like a guided missile, seeking out and destroying cancer cells that have spread throughout the body when other treatments haven't worked well enough.

Think of this treatment as a highly specialized therapy that combines radioactive particles with a targeting system. The targeting part finds prostate cancer cells wherever they might be hiding in your body, while the radioactive part delivers precise treatment directly to those cells.

What is Lutetium Lu 177 Vipivotide Tetraxetan?

Lutetium Lu 177 vipivotide tetraxetan is a radiopharmaceutical, which means it's a medication that contains radioactive material used for medical treatment. It's specifically designed to treat prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer.

The medication targets a protein called PSMA that's found on prostate cancer cells. When injected into your bloodstream, it travels throughout your body and attaches to these cancer cells, delivering targeted radiation therapy directly where it's needed most.

This treatment is also known by its brand name Pluvicto. It received approval from the FDA in 2022 as a breakthrough therapy for men whose prostate cancer has spread and no longer responds to hormone therapy.

What is Lutetium Lu 177 Vipivotide Tetraxetan Used For?

This medication is specifically used to treat metastatic castration-resistant prostate cancer (mCRPC) that tests positive for PSMA. This means your prostate cancer has spread to other parts of your body and no longer responds to treatments that lower testosterone levels.

Your doctor will only recommend this treatment if you've already tried other therapies like androgen receptor pathway inhibitors or taxane-based chemotherapy. These might include medications like enzalutamide, abiraterone, or docetaxel chemotherapy.

Before starting treatment, you'll need a special scan called a PSMA PET scan to confirm that your cancer cells have enough PSMA protein for the treatment to work effectively. This scan helps your medical team determine if you're a good candidate for this therapy.

How Does Lutetium Lu 177 Vipivotide Tetraxetan Work?

This medication works through a two-part system that's quite remarkable in its precision. The vipivotide part acts like a homing device, specifically seeking out and binding to PSMA proteins that are abundant on prostate cancer cells.

Once attached to the cancer cells, the lutetium Lu 177 part delivers targeted radiation therapy. This radioactive component emits beta particles that travel a very short distance, typically less than 2 millimeters, which means they primarily affect the cancer cells while minimizing damage to nearby healthy tissue.

The treatment is considered moderately potent in the world of cancer therapies. While it's not as immediately aggressive as some chemotherapy treatments, it's designed to work steadily over time, gradually weakening and destroying cancer cells throughout your body.

How Should I Take Lutetium Lu 177 Vipivotide Tetraxetan?

This medication is given as an intravenous infusion, which means it's delivered directly into your bloodstream through a vein in your arm. You'll receive this treatment at a specialized nuclear medicine facility or hospital that's equipped to handle radioactive medications safely.

Before your treatment, you'll need to drink plenty of fluids to help protect your kidneys and ensure you're well-hydrated. Your medical team will give you specific instructions, but generally, you should drink at least 1-2 liters of water in the hours leading up to your infusion.

The actual infusion takes about 30 minutes to complete. During this time, you'll be monitored closely by specially trained healthcare professionals. You might feel a slight cooling sensation as the medication enters your bloodstream, but most people tolerate the infusion process quite well.

After your treatment, you'll need to follow specific radiation safety precautions for a few days. This includes limiting close contact with pregnant women, children, and pets, as well as using separate bathroom facilities when possible to protect others from any radioactive material that might be eliminated from your body.

How Long Should I Take Lutetium Lu 177 Vipivotide Tetraxetan For?

The typical treatment plan involves receiving six doses of this medication, with each dose spaced about 6 weeks apart. This means your complete treatment course will span approximately 5-6 months from start to finish.

Your doctor will monitor your response to treatment and your overall health throughout this period. Some men complete all six planned treatments, while others might need to stop earlier due to side effects or if their cancer progresses despite treatment.

Between treatments, you'll have regular check-ups including blood tests to monitor your blood cell counts, kidney function, and liver function. These tests help your medical team ensure that your body is handling the treatment well and that it's safe to continue.

The spacing between treatments is important because it allows your body time to recover from each dose while maintaining the treatment's effectiveness against cancer cells. Your doctor will work with you to determine the best schedule based on your individual response and overall health.

What Are the Side Effects of Lutetium Lu 177 Vipivotide Tetraxetan?

Like most cancer treatments, this medication can cause side effects, though many people find them manageable with proper support and care. The most common side effects are related to how the treatment affects your blood cells and digestive system.

The most frequently reported side effects that you might experience include:

• Fatigue and feeling more tired than usual
• Nausea and occasional vomiting
• Decreased appetite
• Diarrhea or changes in bowel movements
• Dizziness or feeling lightheaded
• Bone pain or muscle aches
• Swelling in your legs or feet

These common side effects usually develop gradually and can often be managed with medications and supportive care from your healthcare team.

More serious side effects can occur, though they're less common. These require immediate medical attention and include:

• Severe drops in blood cell counts (anemia, low white blood cells, or low platelets)
• Kidney problems, which might show up as changes in urination or swelling
• Severe dehydration from persistent vomiting or diarrhea
• Signs of infection like fever, chills, or persistent cough
• Unusual bleeding or bruising
• Severe fatigue that interferes with daily activities

Your medical team will monitor you closely for these more serious effects through regular blood tests and check-ups throughout your treatment.

There are also some rare but potentially serious long-term effects to be aware of. These include the possibility of developing secondary cancers years after treatment, though this risk needs to be weighed against the benefits of treating your current cancer. Your doctor will discuss these risks with you in detail.

Who Should Not Take Lutetium Lu 177 Vipivotide Tetraxetan?

This treatment isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for your specific situation. The most important factor is that your cancer must test positive for PSMA protein, as the treatment won't work effectively without this target.

You should not receive this treatment if you have certain health conditions that could make it dangerous:

• Severe kidney disease or kidney failure
• Severe bone marrow problems or very low blood cell counts
• Active, uncontrolled infections
• Severe liver disease
• Recent major surgery or radiation therapy
• Certain heart conditions that make you unable to tolerate the treatment

Your doctor will also consider your overall health and life expectancy when deciding if this treatment is appropriate for you.

Special precautions are needed if you're planning to have children in the future. This treatment can affect fertility in men, and you should discuss family planning options with your doctor before starting treatment. You'll also need to use effective contraception during treatment and for several months afterward.

If you have diabetes, kidney problems, or other chronic conditions, your doctor will need to monitor you extra carefully during treatment. These conditions don't necessarily prevent you from receiving the treatment, but they require additional attention and possibly modified dosing.

Lutetium Lu 177 Vipivotide Tetraxetan Brand Name

The brand name for lutetium Lu 177 vipivotide tetraxetan is Pluvicto. This medication is manufactured by Novartis and was specifically developed for treating advanced prostate cancer.

When you're discussing this treatment with your healthcare team or researching information, you might see it referred to by either its generic name (lutetium Lu 177 vipivotide tetraxetan) or its brand name (Pluvicto). Both names refer to the same medication.

Pluvicto is currently the only available brand of this specific radiopharmaceutical. Because it's a highly specialized treatment that requires special handling and administration, it's only available through certified nuclear medicine facilities and cancer treatment centers.

Lutetium Lu 177 Vipivotide Tetraxetan Alternatives

While Pluvicto is a unique treatment, there are other options available for men with advanced prostate cancer. Your doctor will help you understand which alternatives might be suitable for your specific situation.

Other targeted therapies for advanced prostate cancer include:

• Radium-223 (Xofigo), another radioactive treatment that targets bone metastases
• Lutetium Lu 177 dotatate (Lutathera), used for certain neuroendocrine tumors
• Hormone therapy drugs like enzalutamide (Xtandi) or abiraterone (Zytiga)
• Chemotherapy options such as docetaxel (Taxotere) or cabazitaxel (Jevtana)
• Immunotherapy treatments like sipuleucel-T (Provenge)

The choice between these treatments depends on many factors, including your cancer's specific characteristics, your previous treatments, your overall health, and your personal preferences.

Some men might receive Pluvicto in combination with other treatments, while others might try it after other therapies have stopped working. Your oncologist will work with you to develop a treatment plan that's tailored to your individual needs and circumstances.

Is Lutetium Lu 177 Vipivotide Tetraxetan Better Than Radium-223?

Both Pluvicto and radium-223 (Xofigo) are radioactive treatments for advanced prostate cancer, but they work in different ways and are used in different situations. Comparing them directly isn't straightforward because they target different aspects of prostate cancer.

Radium-223 specifically targets bone metastases and is designed to help with bone pain and strengthen bones affected by cancer. It's particularly useful when prostate cancer has spread primarily to the bones and you're experiencing significant bone pain.

Pluvicto, on the other hand, can target prostate cancer cells wherever they are in the body, not just in bones. It's designed to work against cancer that has spread to various organs and tissues, making it potentially more versatile for widespread disease.

The choice between these treatments depends on your specific situation. Your doctor will consider factors like where your cancer has spread, your PSMA levels, your bone health, and your previous treatments to determine which option might work better for you.

Some men might even receive both treatments at different points in their cancer journey, as they serve different purposes in managing advanced prostate cancer.